Mori Arkin
InvestorFounder & Chairman at Arkin Capital
Israel
Writes $5K – $50K checks · typically $25K
About
Mori Arkin took over Agis, the pharmaceutical company founded by his father, and grew it into a global business in topical generics and active pharmaceutical ingredients before it was sold to Perrigo in 2005. He founded Arkin in 2009 as an investment platform focused on life sciences, including pharmaceuticals, biotechnology, and medical devices, and continues to advise the firm and take an active role in its life sciences investments. He holds an undergraduate degree in Psychology from Tel Aviv University and has published research on Renaissance art.
Invests in
BiotechHealthtechMedical Devices
Experience
- arkin holdingsChairmancurrent2008 — present
- arkin holdingsChairmancurrent2008 — presentIsrael
Investments
Board seats
OdysightSol-Gel TechnologiesVirility Medical
Per the firm's website.
Colleagues at Arkin Capital
Adar Makovski Silverstein
Principal at Arkin Capital
Alon Lazarus
Managing Partner at Arkin Capital
Avital Adler
Principal at Arkin Capital
Benzion Amoyav
Investment Analyst at Arkin Capital
Chen Koton
Direct Equity at Arkin Capital
Dana Azulay
Bookkeeper at Arkin Capital
Danny Kleinhendler
Legal Counsel at Arkin Capital
David Alterman
Principal at Arkin Capital